claim: anti-hpv type 6 has a lower gmt ratio (95% ci) than anti-hpv type 16 in group 1 compared to group 2.
article_headline: naci statement: hpv vaccine update - canada.ca
initial_claim: new hpv vaccine offers greater protection against cervical cancer than current vaccine